Natasha Hernday's Net Worth
$363 Thousand
Who is Natasha Hernday?
Natasha Hernday does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include XOMA Corp, ALPINE IMMUNE SCIENCES, INC., PDL BIOPHARMA, INC., and Janux Therapeutics, Inc..
SEC CIK
Natasha Hernday's CIK is 0001780547
Past Insider Trading and Trends
2024 was Natasha Hernday's most active year for acquiring shares with 9 total transactions. Natasha Hernday's most active month to acquire stocks was the month of June. 2024 was Natasha Hernday's most active year for disposing of shares, totalling 5 transactions. Natasha Hernday's most active month to dispose stocks was the month of April. 2020 saw Natasha Hernday paying a total of $530,775.73 for 176,748 shares, this is the most they've acquired in one year. In 2024 Natasha Hernday cashed out on 60,150 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
XOMA Corp (XOMA) Snapshot price: $28.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.04K |
—
|
—
| 3.04K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
∞
| 4K |
$25.00 | $100,000.00 | 4K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALPINE IMMUNE SCIENCES, INC. (ALPN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +51.65% | 25.83K |
—
|
—
| 75.83K |
Aug 19
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Janux Therapeutics, Inc. (JANX) Snapshot price: $42.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +24.62% | 1.23K |
—
|
—
| 6.23K |
Jul 19
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||